Persist AI

Developing long-lasting drug formulations 50% faster

HealthcareDrug Discovery and DeliveryMachine LearningRoboticsMicrofluidicsNanotechnologyTherapeutics http://www.persist-ai.com ↗

Company facts

Growth-stage
Founded
2022
Employees
6
Headquarters
United States

About

It takes 5 years for pharma to develop long lasting drug injections for chronic diseases like cancer and diabetes. Persist uses AI-driven automation to reduce formulation development time down to 2 years, a ~50% reduction.